Cargando…
Retinal Endovascular Surgery with Tissue Plasminogen Activator Injection for Central Retinal Artery Occlusion
PURPOSE: To report 2 cases of central retinal artery occlusion (CRAO) who underwent retinal endovascular surgery with injection of tissue plasminogen activator (tPA) into the retinal artery and showed a remarkable improvement in visual acuity and retinal circulation. METHODS: Standard 25-G vitrectom...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6047559/ https://www.ncbi.nlm.nih.gov/pubmed/30022948 http://dx.doi.org/10.1159/000489696 |
_version_ | 1783339962367737856 |
---|---|
author | Takata, Yuta Nitta, Yasuhito Miyakoshi, Akio Hayashi, Atsushi |
author_facet | Takata, Yuta Nitta, Yasuhito Miyakoshi, Akio Hayashi, Atsushi |
author_sort | Takata, Yuta |
collection | PubMed |
description | PURPOSE: To report 2 cases of central retinal artery occlusion (CRAO) who underwent retinal endovascular surgery with injection of tissue plasminogen activator (tPA) into the retinal artery and showed a remarkable improvement in visual acuity and retinal circulation. METHODS: Standard 25-G vitrectomy was performed under local anesthesia. Simultaneously, tPA (80,000 units/mL) solution was injected into the retinal artery of the optic disc for 2–3 min using a microneedle. Changes in visual acuity, fundus photography, optical coherence tomography (OCT), fluorescein angiography, and laser speckle flowgraphy (LSFG) results were examined. RESULTS: Both cases could be treated within 12 h after the onset of CRAO. Case 1 was a 47-year-old woman. Her visual acuity improved from counting fingers before operation to 0.08 logMAR 1 month after the surgery. However, thinning of the retina at the macula was observed by OCT. Case 2 was a 70-year-old man. His visual acuity improved from counting fingers to 0.1 logMAR 2 months after the surgery. Both fluorescein angiography and LSFG showed improvement in retinal circulation after the surgery in case 2. CONCLUSIONS: Retinal endovascular surgery with injection of tPA into the retinal artery was feasible and may be a way to improve visual acuity and retinal circulation when performed in the acute phase of CRAO. |
format | Online Article Text |
id | pubmed-6047559 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | S. Karger AG |
record_format | MEDLINE/PubMed |
spelling | pubmed-60475592018-07-18 Retinal Endovascular Surgery with Tissue Plasminogen Activator Injection for Central Retinal Artery Occlusion Takata, Yuta Nitta, Yasuhito Miyakoshi, Akio Hayashi, Atsushi Case Rep Ophthalmol Case Report PURPOSE: To report 2 cases of central retinal artery occlusion (CRAO) who underwent retinal endovascular surgery with injection of tissue plasminogen activator (tPA) into the retinal artery and showed a remarkable improvement in visual acuity and retinal circulation. METHODS: Standard 25-G vitrectomy was performed under local anesthesia. Simultaneously, tPA (80,000 units/mL) solution was injected into the retinal artery of the optic disc for 2–3 min using a microneedle. Changes in visual acuity, fundus photography, optical coherence tomography (OCT), fluorescein angiography, and laser speckle flowgraphy (LSFG) results were examined. RESULTS: Both cases could be treated within 12 h after the onset of CRAO. Case 1 was a 47-year-old woman. Her visual acuity improved from counting fingers before operation to 0.08 logMAR 1 month after the surgery. However, thinning of the retina at the macula was observed by OCT. Case 2 was a 70-year-old man. His visual acuity improved from counting fingers to 0.1 logMAR 2 months after the surgery. Both fluorescein angiography and LSFG showed improvement in retinal circulation after the surgery in case 2. CONCLUSIONS: Retinal endovascular surgery with injection of tPA into the retinal artery was feasible and may be a way to improve visual acuity and retinal circulation when performed in the acute phase of CRAO. S. Karger AG 2018-06-22 /pmc/articles/PMC6047559/ /pubmed/30022948 http://dx.doi.org/10.1159/000489696 Text en Copyright © 2018 by S. Karger AG, Basel http://creativecommons.org/licenses/by-nc/4.0/ This article is licensed under the Creative Commons Attribution-NonCommercial-4.0 International License (CC BY-NC) (http://www.karger.com/Services/OpenAccessLicense). Usage and distribution for commercial purposes requires written permission. |
spellingShingle | Case Report Takata, Yuta Nitta, Yasuhito Miyakoshi, Akio Hayashi, Atsushi Retinal Endovascular Surgery with Tissue Plasminogen Activator Injection for Central Retinal Artery Occlusion |
title | Retinal Endovascular Surgery with Tissue Plasminogen Activator Injection for Central Retinal Artery Occlusion |
title_full | Retinal Endovascular Surgery with Tissue Plasminogen Activator Injection for Central Retinal Artery Occlusion |
title_fullStr | Retinal Endovascular Surgery with Tissue Plasminogen Activator Injection for Central Retinal Artery Occlusion |
title_full_unstemmed | Retinal Endovascular Surgery with Tissue Plasminogen Activator Injection for Central Retinal Artery Occlusion |
title_short | Retinal Endovascular Surgery with Tissue Plasminogen Activator Injection for Central Retinal Artery Occlusion |
title_sort | retinal endovascular surgery with tissue plasminogen activator injection for central retinal artery occlusion |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6047559/ https://www.ncbi.nlm.nih.gov/pubmed/30022948 http://dx.doi.org/10.1159/000489696 |
work_keys_str_mv | AT takatayuta retinalendovascularsurgerywithtissueplasminogenactivatorinjectionforcentralretinalarteryocclusion AT nittayasuhito retinalendovascularsurgerywithtissueplasminogenactivatorinjectionforcentralretinalarteryocclusion AT miyakoshiakio retinalendovascularsurgerywithtissueplasminogenactivatorinjectionforcentralretinalarteryocclusion AT hayashiatsushi retinalendovascularsurgerywithtissueplasminogenactivatorinjectionforcentralretinalarteryocclusion |